Denosumab

Details

Files

Generic Name:

Denosumab

Project Status:

Complete

Therapeutic Area:

Prevention of skeletal-related events due to bone metastases from solid tumours

Manufacturer:

Amgen Canada Inc.

Call for patient/clinician input open:

May 27, 2011

Brand Name:

XGEVA

Project Line:

Reimbursement Review

Project Number:

SR0235-000

Call for patient/clinician input closed:

June 24, 2011

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

Prevention of skeletal-related events due to bone metastases from solid tumours

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

November 16, 2011

Last Updated : June 6, 2011